1383934-30-2

Upstream product

• 1383934-16-4 N-[4-chloro-3-(trifluoromethyl)benzyl]-2-ethoxy-6-hydroxybenzamide 
• 154364-61-1 ethyl 6-ethoxy-2-hydroxybenzoate 
• 480439-13-2 2-ethoxy-6-hydroxybenzoic acid 
• 1311423-91-2 N-(4-chloro-3-(trifluoromethyl)phenyl)-2-ethoxy-6-hydroxybenzamide 

Downstream Products

• 1383934-32-4 3-[4-chloro-3-(trifluoromethyl)phenyl]-5-ethoxy-3,4-dihydro-2H-benzo[e][l,3]oxazine 

Relevant academic research and scientific papers

HISTONE ACETYLTRANSFERASE ACTIVATORS AND COMPOSITIONS AND USES THEREOF

The invention provides pharmaceutical compositions and methods for treating cancer, neurodegenerative disorders, conditions associated with accumulated amyloid-beta peptide deposits, Tau protein levels, and/or accumulations of alpha-synuclein by administering a HAT modulator and a HDAC modulator to a subject.

HISTONE ACETYLTRANSFERASE MODULATORS AND USESE THEREOF

The invention provides compounds and compositions comprising compounds that modulate histone acyl transferase (HAT). The invention further provides methods for treating neurodegenerative disorders, conditions associated with accumulated amyloid-beta peptide deposits, Tau protein levels, and/or accumulations of alpha-synuclein as well as cancer by administering a compound that modulates HAT to a subject.